| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,382 |
2,903 |
$239K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
308 |
303 |
$121K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,234 |
2,767 |
$76K |
| 80050 |
General health panel |
1,587 |
1,531 |
$69K |
| 80061 |
Lipid panel |
2,469 |
2,350 |
$29K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
718 |
683 |
$19K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,603 |
1,541 |
$14K |
| 80053 |
Comprehensive metabolic panel |
721 |
664 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
679 |
629 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
315 |
288 |
$4K |
| 84439 |
|
370 |
346 |
$3K |
| 82607 |
|
187 |
178 |
$3K |
| 82728 |
|
176 |
165 |
$2K |
| 82746 |
|
115 |
109 |
$1K |
| 83037 |
|
103 |
91 |
$821.29 |
| 83550 |
|
75 |
73 |
$587.00 |
| 83540 |
|
87 |
84 |
$534.55 |
| 82043 |
|
57 |
55 |
$295.18 |
| 84153 |
|
17 |
16 |
$291.24 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
30 |
27 |
$214.96 |
| 83721 |
|
24 |
12 |
$103.00 |
| 83690 |
|
13 |
12 |
$89.57 |
| 82247 |
|
18 |
14 |
$80.32 |
| 85007 |
|
33 |
26 |
$0.00 |